NCT02105285View on ClinicalTrials.gov

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

OPC-1085EL ophthalmic solution

DRUG

Carteolol long-acting ophthalmic solution

Trial Locations (1)

Unknown

Kansai Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY